Current longevity research rests on a costly assumption: that dying at 65 is just a botched attempt at reaching 100. We view these signaling networks as broken machinery, but we’re missing the possibility that they’re operating on an entirely different, highly optimized frequency.

I see two ways to explain why human lifespan varies so much. Only one of them actually respects the biology.

Hypothesis 1: The Universal Entropy Model. This is the safe status quo. It assumes aging is just a random buildup of errors—specifically, that kinase substrate promiscuity increases until a cell’s signal-to-noise ratio simply collapses. In this view, a 60-year-old is just a centenarian who had bad luck with their molecular proofreading.

Hypothesis 2: Adaptive Kinetic Divergence (AKD). This is a tougher pill to swallow. It suggests human populations are split into distinct signaling phenotypes. Some people are tuned for high-gain, low-fidelity signaling. Their kinases move faster, their immune responses are more explosive, and their metabolic flux is higher. That’s a massive evolutionary win in high-stress or pathogenic environments. But this high-gain state comes with a price: a faster-drifting phosphoproteome. These individuals aren't "failing" to hit 100. They're following a biological script that prioritizes immediate resilience over long-term stability.

If AKD is real—and the data points that way—our current approach to longevity won't work. We’re trying to force high-gain individuals into a low-gain centenarian template. When we give longevity drugs designed for stability to someone whose kinome is built for speed, we don't get a longer healthspan; we get signaling incoherence.

We've got to stop hunting for "longevity genes" and start mapping Kinetic Profiles. We need to admit that for some, the universal baseline we’re chasing is actually a metabolic prison.

I want to find collaborators for a high-resolution phosphoproteomic screen of "early-onset" aging phenotypes. We have to stop treating these deaths as errors and see them as a different class of biology. If we’re going to extend these lives, we can’t just try to "fix" them—we have to learn how to re-tune them.